Torbjörn Callréus

Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation

Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, Flemming Skjøth et al. · Journal of the American College of Cardiology · 2013 · 401 citations

Thrombosis, Cardiovascular Disease, Dabigatran Etexilate +8

Use of Angiotensin Receptor Blockers and the Risk of Cancer

Björn Pasternak, Henrik Svanström, Torbjörn Callréus et al. · Circulation · 2011 · 113 citations · Full text

Cardiovascular drugs and the risk of suicide: a nested case-control study

Torbjörn Callréus, Ulla Agerskov Andersen, Jesper Hallas et al. · European Journal of Clinical Pharmacology · 2007 · 45 citations

Substance Abuse, Cardiovascular Drugs, Cardiovascular Disease +12

Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®

Maurizio Sessa, Annamaria Mascolo, Torbjörn Callréus et al. · Scientific Reports · 2019 · 43 citations · Full text

World Health Organization, Gynecology, Direct-acting Oral Anticoagulants +19

Changes in gastrointestinal motility influence the absorption of desmopressin

Torbjörn Callréus, Jonas Lundahl, Peter Höglund et al. · European Journal of Clinical Pharmacology · 1999 · 27 citations

Gastrointestinal Pharmacology, Medicine, Physiology +6